GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Ending Cash Position

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Ending Cash Position : $382.4 Mil (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Ending Cash Position?

Taro Pharmaceutical Industries's Ending Cash Position for the quarter that ended in Dec. 2023 was $382.4 Mil.

Taro Pharmaceutical Industries's quarterly Ending Cash Position increased from Jun. 2023 ($124.2 Mil) to Sep. 2023 ($269.0 Mil) and increased from Sep. 2023 ($269.0 Mil) to Dec. 2023 ($382.4 Mil).

Taro Pharmaceutical Industries's annual Ending Cash Position declined from Mar. 2021 ($605.2 Mil) to Mar. 2022 ($251.1 Mil) and declined from Mar. 2022 ($251.1 Mil) to Mar. 2023 ($154.5 Mil).


Taro Pharmaceutical Industries Ending Cash Position Historical Data

The historical data trend for Taro Pharmaceutical Industries's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Ending Cash Position Chart

Taro Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 567.45 513.35 605.18 251.13 154.50

Taro Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.97 154.50 124.17 269.01 382.41

Taro Pharmaceutical Industries Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Taro Pharmaceutical Industries's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=251.134+-96.639
=154.5

Taro Pharmaceutical Industries's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=269.011+113.398
=382.4


Taro Pharmaceutical Industries Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Executives
Sun Pharma Global Inc 10 percent owner
Sun Pharmaceutical Industries Ltd 10 percent owner, other: Affiliated Party 17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd. 10 percent owner KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc 10 percent owner FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Headlines

From GuruFocus

Taro to Announce Third Quarter Results on January 27, 2022

By Business Wire Business Wire 01-21-2022

Taro Announces Resignation of Chief Financial Officer

By Business Wire Business Wire 07-14-2021

Taro to Release Third Quarter Results on January 24, 2023

By Business Wire Business Wire 01-19-2023

Taro to Release First Quarter Results on July 27, 2022

By Business Wire Business Wire 07-26-2022

Taro Appoints New Chief Financial Officer

By Business Wire Business Wire 12-01-2021

Taro to Release Full Year Results on May 23, 2023

By Business Wire Business Wire 05-18-2023